• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深静脉血栓形成管理的差异:对关键路径潜在影响的启示

Variation in the management of deep vein thrombosis: implications for the potential impact of a critical pathway.

作者信息

Schoenenberger R A, Pearson S D, Goldhaber S Z, Lee T H

机构信息

Section for Clinical Epidemiology, Harvard Community Health Plan, Brigham and Women's Hospital, Boston, Massachusetts, USA.

出版信息

Am J Med. 1996 Mar;100(3):278-82. doi: 10.1016/S0002-9343(97)89485-5.

DOI:10.1016/S0002-9343(97)89485-5
PMID:8629672
Abstract

PURPOSE

To evaluate the potential impact of a practice guideline in the form of a critical pathway on variation and quality of care in patients with deep vein thrombosis (DVT).

METHODS

Goals were identified for key steps and processes that were believed to be important for meeting a length-of-stay (LOS) goal of 5.5 days, and for improving quality of care for patients with DVT. Data collected via chart review were used to determine the percentage o patients with uncomplicated DVT admitted in the year after October 1, 1992, whose management would have met these goals.

RESULTS

Only 11 (12%) of 92 eligible patients with a primary discharge diagnosis of DVT met the LOS goal. In 30%, the activated partial thromboplastin time (aPTT) was >60 seconds within a target of 12 hours after admission. The goals for the initiation of warfarin (within 12 hours after aPTT >60 seconds) and the achievement of a therapeutic international normalized ratio (INR) level (within 120 hours) were met in 51% and 58% of patients, respectively. The target duration of intravenous heparin therapy was achieved in 78% of patients. Only 18% of patients, however, were discharged within 12 hours after 96 hours of heparin therapy had been given and a therapeutic INR had been achieved.

CONCLUSIONS

These data demonstrate considerable variation in management of uncomplicated DVT at a single hospital, suggesting that a critical pathway could have impact on both LOS and quality of care.

摘要

目的

评估以关键路径形式呈现的实践指南对深静脉血栓形成(DVT)患者护理差异及质量的潜在影响。

方法

确定了关键步骤和流程的目标,这些步骤和流程被认为对于实现5.5天的住院时长(LOS)目标以及改善DVT患者的护理质量至关重要。通过病历审查收集的数据用于确定1992年10月1日之后入院的无并发症DVT患者中,其治疗管理符合这些目标的患者百分比。

结果

92例以DVT为主要出院诊断的合格患者中,只有11例(12%)达到了住院时长目标。30%的患者在入院后12小时内活化部分凝血活酶时间(aPTT)>60秒,这在目标范围内。分别有51%和58%的患者达到了华法林起始治疗(aPTT>60秒后12小时内)和达到治疗性国际标准化比值(INR)水平(120小时内)的目标。78%的患者达到了静脉注射肝素治疗的目标时长。然而,只有18%的患者在接受96小时肝素治疗且达到治疗性INR后12小时内出院。

结论

这些数据表明,一家医院在无并发症DVT的治疗管理方面存在相当大的差异,这表明关键路径可能对住院时长和护理质量都有影响。

相似文献

1
Variation in the management of deep vein thrombosis: implications for the potential impact of a critical pathway.深静脉血栓形成管理的差异:对关键路径潜在影响的启示
Am J Med. 1996 Mar;100(3):278-82. doi: 10.1016/S0002-9343(97)89485-5.
2
Comparison between critical pathway guidelines and management of deep-vein thrombosis: retrospective cohort study.关键路径指南与深静脉血栓形成管理的比较:回顾性队列研究。
Croat Med J. 2000 Jun;41(2):163-7.
3
A critical pathway to treat proximal lower-extremity deep vein thrombosis.治疗下肢近端深静脉血栓形成的关键路径。
Am J Med. 1996 Mar;100(3):283-9. doi: 10.1016/S0002-9343(97)89486-7.
4
The successful application of a heparin nomogram in a community hospital.肝素剂量表在一家社区医院的成功应用。
Arch Intern Med. 1995 Oct 23;155(19):2095-100.
5
An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.一项关于每日一次剂量的依诺肝素与普通肝素治疗下肢近端深静脉血栓形成的疗效和安全性的开放标签对照研究。
Thromb Res. 2004;114(3):149-53. doi: 10.1016/j.thromres.2004.05.009.
6
Clinical pathways--an evaluation of its impact on the quality of care in an acute care general hospital in Singapore.临床路径——对新加坡一家急症综合医院护理质量影响的评估。
Singapore Med J. 2000 Jul;41(7):335-46.
7
[Is a three-month therapy with warfarin adequate for effective therapy of patients after an episode of venous thrombosis].华法林三个月疗程对静脉血栓形成发作后患者进行有效治疗是否足够?
Ter Arkh. 2008;80(7):50-4.
8
Home treatment of deep vein thrombosis: a two-years experience of a single institution.深静脉血栓形成的家庭治疗:一家机构的两年经验
Haematologica. 1998 May;83(5):438-41.
9
Effect of weight, sex, age, clinical diagnosis, and thromboplastin reagent on steady-state intravenous heparin requirements.
Arch Intern Med. 1997 Nov 24;157(21):2468-72.
10
[Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].[全膝关节置换术后低分子肝素与华法林联合抗凝治疗的并发症及风险——我们的经验]
Acta Chir Orthop Traumatol Cech. 2004;71(4):237-44.

引用本文的文献

1
Critical pathways for patients with acute chest pain at low risk.低风险急性胸痛患者的关键路径
J Thromb Thrombolysis. 2002 Apr;13(2):89-96. doi: 10.1023/a:1016246814235.
2
Deep Venous Thrombosis: Early Discharge Strategies and Outpatient Management.深静脉血栓形成:早期出院策略与门诊管理
J Thromb Thrombolysis. 1997;4(3/4):365-374. doi: 10.1023/a:1008849416842.
3
Deep venous thrombosis: early discharge strategies and outpatient management.
J Thromb Thrombolysis. 1999 Apr;7(2):113-22. doi: 10.1023/a:1008873201503.
4
Do practice guidelines augment drug utilisation review?实践指南是否会加强药物利用审查?
Pharmacoeconomics. 1997 Dec;12(6):648-66. doi: 10.2165/00019053-199712060-00005.